Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocurcumin in prediabetes
IRCT20170221032698N3Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin in prediabetes, sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Change in anthropometric parameters, Change in glycemic indices and 3 more. Started Jun 2024; status: completed.
02
Drugs
nanocurcumin
03
Conditions
prediabetes
Beyond the preview
Go deeper on IRCT20170221032698N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170221032698N3.